OBJECTIVES: There is little information on lipid metabolism after sauna treatment in the literature. The present research is aimed to determine the influence of sauna baths on fat metabolism in young women. MATERIALS AND METHODS: Twenty healthy, eumenhorreic, female volunteers (19-21 yr old) were exposed to Finnish sauna bath seven times every second day. In group I (n = 10) each time the sauna treatment lasted 30 min, whereas in group II (n = 10) 40 min with 5-minute break to cool down. Body mass, heart rate and blood pressure were measured before and after sauna bath. Rectal temperature was monitored during stay in sauna room. Prior to the sauna bath and during its last two minutes the minute oxygen uptake and the level of CO2 exhalation were analyzed in the exhaled air, and the respiratory quotient RQ was calculated. In the blood samples collected before the sauna bath and immediately afterwards hematocrit, hemoglobin, and lipid profile--total lipids, free fatty acids, total free fatty acids, triacylglycerols, total cholesterol (TC), high density lipids (HDL), low density lipids (LDL) were analyzed. RESULTS: Rectal temperature was lower in the last sauna bath than in the first one. Losses of plasma were greater during the seventh bath than during the first one. Acceleration of the metabolism of lipids occurs after every sauna bath. A reduced level of TC and LDLC and a raised level of HDL was observed after repeated sauna baths. CONCLUSION: After 2 weeks of repeated sauna session some changes in total cholesterol and concentration of LDLC were observed, while concentration of HDLC increased after 7th sauna bath in group I. Those kinds of changes may be good prognoses of ischemic heart disease prevention, but further research on the influence of sauna on fat metabolism is needed.

BACKGROUND: The increased level of LDL-c in the serum has a high risk and the increased serum HDL-c level has a low risk for the development of atherosclerosis. The effect of Nigella sativa on levels of cholesterol fractions were determined in this study on rats. METHODS: 24 albino rats of 08 weeks age having equal number of males and females were kept at optimum atmospheric condition. The blood samples were taken at the start and different control and experimental diets were given for 20 weeks. The experimental diets were added with Nigella sativa as 30 mg/kg body weight. The blood samples were taken at the end of study. The blood samples drawn at the start and end of the study were estimated for serum cholesterol. The results of control and experimental groups were compared. RESULTS: Total serum cholesterol in the control group showed increase from 8.3+/-3.30 to 13.96+/-9.3 at 20 weeks. The serum HDL cholesterol showed increase from 44.4+/-6.12 to 80.45+/-5.95 level at 20 weeks. The serum LDL cholesterol showed increase from 8.3+/-3.30 to 13.96+/-9.3 at 20 weeks. The total serum cholesterol in experimental group was increased from 76.9+/-6.5 to 117.5+/-6.65 at 20 weeks. The serum HDL cholesterol levels was increased from 41.7+/-4.9 to 83.42+/-5.92 at 20 weeks as compared with control group. The LDL cholesterol levels were decreased from 12.7+/-6.9 to 8.5+/-7.8 at 20 weeks. CONCLUSION: This study shows significant decrease in serum low density lipoprotein cholesterol level, and increase in serum high density lipoprotein cholesterol levels.

BACKGROUND:Reports have shown that visceral adipose tissue (VAT) is more closely linked to cardiovascular risk factors (CRFs) than subcutaneous adipose tissue (SAT). We aimed to elucidate preferential abdominal fat loss and the correlations between abdominal fat reductions and changes in CRFs achieved with a moderate low-carbohydrate diet (LCD) in patients with type 2 diabetes (T2DM).

PATIENTS AND METHODS:Fifty-two outpatients (28 men and 24 women, mean age± SD: 60.0 ± 10.5 years) with hemoglobin A(1c) (HbA(lc)) levels ≥ 6.5% were on an LCD for 6 months. Over a 6-month period, we measured their abdominal fat distribution (using CT) and assessed CRFs, including body mass index (BMI), HbA(1c), fasting blood glucose (FBG), serum insulin, high-densitylipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride levels.

RESULTS:The patients showed good compliance with the LCD (1812± 375 kcal/day, % carbohydrate:fat:protein = 35:40:19 for men; 1706 ± 323 kcal/day, % carbohydrate:fat:protein = 41:36:21 for women). Significant decreases (P = 0.05) in BMI and HbA(1c) levels were observed, along with an increase in HDL-C (P = 0.021) in men and a decrease in LDL-C (P = 0.001) inwomen. VAT (-21.6 cm(2), P<0.001 in men; -19.6 cm(2), P<0.001 in women) and SAT (-13.5 cm(2), P = 0.004 in men; -19.1 cm(2), P = 0.003 in women) significantly decreased. The loss of VAT (%ΔVAT) was greater than that of SAT (%ΔSAT) in women (P = 0.022). A similar but not significant predominance of VAT loss was detected in men (P = 0.111). In women, the %ΔSAT significantly correlated with changes in FBG (ΔFBG) (r = 0.417) and HDL-C (ΔHDL) (r = -0.720), as was %ΔVAT with changesin triglyceride (ΔTG) (r = 0.591).

CONCLUSION:Six months of a moderate LCD resulted in preferential VAT loss only in women, with significant correlations between %ΔSAT and both ΔHDL and ΔFBG, as well as between %ΔVAT and ΔTG. Our results suggest that an LCD has the potential to reduce abdominal fat in patients with T2DM and deterioration of serum lipid profiles.

BACKGROUND: Guidelines established by the National Cholesterol Education Program (NCEP) promote exercise and weight loss for the treatment of abnormal lipoprotein levels. Little is known, however, about the effects of exercise or the NCEP diet, which is moderately low in fat and cholesterol, in persons with lipoprotein levels that place them at high risk for coronary heart disease.

METHODS: We studied plasma lipoprotein levels in 180 postmenopausal women, 45 through 64 years of age, and 197 men, 30 through 64 years of age, who had low high-density lipoprotein (HDL) cholesterol levels (125 mg per deciliter but<210 mg per deciliter in women and>125 mg per deciliter but<190 mg per deciliter in men). The subjects were randomly assigned to aerobic exercise, the NCEP Step 2 diet, or diet plus exercise, or to a control group, which received no intervention.

RESULTS: Dietary intake of fat and cholesterol decreased during the one-year study (P<0.001), as did body weight, in women and men in either the diet group or the diet-plus-exercise group, as compared with the controls (P<0.001) and the exercise group (P<0.05), in which dietary intake and body weight were unchanged. Changes in HDL cholesterol and triglyceride levels and the ratio of total to HDL cholesterol did not differ significantly among the treatment groups, for subjects of either sex. The serum level of LDL cholesterol was significantly reduced among women (a decrease of 14.5+/-22.2 mg per deciliter) and men (a decrease of 20.0+/-17.3 mg per deciliter) in the diet-plus-exercise group, as compared with the control group (women had a decrease of 2.5+/-16.6 mg per deciliter, P<0.05; men had a decrease of 4.6+/-21.1 mg per deciliter, P<0.001). The reduction in LDL cholesterol in men in the diet-plus-exercise group was also significant as compared with that among the men in the exercise group (3.6+/-18.8 mg per deciliter, P<0.001). In contrast, changes in LDL cholesterol levels were not significant among the women (a decrease of 7.3+/-18.9 mg per deciliter) or the men (10.8+/-18.8 mg per deciliter) in the diet group, as compared with the controls.

CONCLUSIONS: The NCEP Step 2 diet failed to lower LDL cholesterol levels in men or women with high-risk lipoprotein levels who did not engage in aerobic exercise. This finding highlights the importance of physical activity in the treatment of elevated LDL cholesterol levels.

BACKGROUND:In order to implement running to promote physical activity, it is essential to quantify the extent to which running improves health.

OBJECTIVE:The aim was to summarise the literature on the effects of endurance running on biomedical indices of health in physically inactive adults.

DATA SOURCES:Electronic searches were conducted in October 2014 on PubMed, Embase, CINAHL, SPORTDiscus, PEDro, the Cochrane Library and LILACS, with no limits of date and language of publication.

STUDY SELECTION:Randomised controlled trials (with a minimum of 8 weeks of running training) that included physically inactive but healthy adults (18-65 years) were selected. The studies needed to compare intervention (i.e. endurance running) and control (i.e., no intervention) groups.

STUDY APPRAISAL AND SYNTHESIS METHODS:Two authors evaluated study eligibility, extracted data, and assessed risk of bias; a third author resolved any uncertainties. Random-effects meta-analyses were performed to summarise the estimates for length of training and sex. A dose-response analysis was performed with random-effects meta-regression in order to investigate the relationship between running characteristics and effect sizes.

RESULTS:After screening 22,380 records, 49 articles were included, of which 35 were used to combine data on ten biomedical indices of health. On average the running programs were composed of 3.7± 0.9 sessions/week, 2.3 ± 1.0 h/week, 14.4 ± 5.4 km/week, at 60-90% of the maximum heart rate, and lasted 21.5 ± 16.8 weeks. After 1 year of training, running was effective in reducing body mass by 3.3 kg [95% confidence interval (CI) 4.1-2.5], body fat by 2.7% (95% CI 5.1-0.2), resting heart rate by 6.7 min(-1) (95% CI 10.3-3.0) and triglycerides by 16.9 mg dl(-1) (95% CI 28.1-5.6). Also, running significantly increased maximal oxygen uptake (VO2max) by 7.1 ml min(-1) kg(-1) (95% CI 5.0-9.1) and high-density lipoprotein (HDL) cholesterol by 3.3 mg dl(-1) (95% CI 1.2-5.4). No significanteffect was found for lean body mass, body mass index, total cholesterol and low-density lipoprotein cholesterol after 1 year of training. In the dose-response analysis, larger effect sizes were found for longer length of training.

LIMITATIONS:It was only possible to combine the data of ten out the 161 outcome measures identified. Lack of information on training characteristics precluded a multivariate model in the dose-response analysis.

CONCLUSIONS:Endurance running was effective in providing substantial beneficial effects on body mass, body fat, resting heart rate, VO2max, triglycerides and HDL cholesterol in physically inactive adults. The longer the length of training, the larger the achieved health benefits. Clinicians and health authorities can use this information to advise individuals to run, and to support policies towards investing in running programs.